Contemporary management of acute coronary syndrome

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Non-ST elevation acute coronary syndromes (NSTE-ACS) encompass unstable angina and non-ST elevation myocardial infarction.
• Patient prognosis in NSTE-ACS varies, with risks of reinfarction and mortality.
• Accurate risk prediction is crucial for guiding NSTE-ACS management.

Purpose of the Study:

• To review modern management strategies for NSTE-ACS.
• To outline risk stratification methods and therapeutic interventions.
• To differentiate treatment approaches based on patient risk levels.

Main Methods:

• Review of current literature on NSTE-ACS management.
• Emphasis on clinical, electrocardiographic, and biochemical risk markers.
• Discussion of pharmacological and interventional treatment options.

Main Results:

• All NSTE-ACS patients benefit from aspirin, clopidogrel, heparin, and anti-ischaemic drugs.
• High-risk patients require glycoprotein IIb/IIIa inhibitors and early coronary arteriography for revascularization.
• Low-risk patients benefit from non-invasive testing, with coronary arteriography indicated if myocardial ischemia is inducible.

Conclusions:

• Risk stratification reliably predicts outcomes in NSTE-ACS.
• A tiered management approach ensures optimal treatment for all NSTE-ACS patients.
• Conservative management is safe for low-risk patients with negative non-invasive testing.